Yahoo
Mail
Summary
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
AZNCF - AstraZeneca PLC
Other OTC - Other OTC Delayed Price. Currency in USD
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Income Statement
All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
44,351,000
44,351,000
37,417,000
26,617,000
24,384,000
Cost of Revenue
12,391,000
12,391,000
12,437,000
5,299,000
4,921,000
Gross Profit
31,960,000
31,960,000
24,980,000
21,318,000
19,463,000
Operating Expenses
Research Development
9,762,000
9,762,000
9,736,000
5,991,000
5,958,000
Selling General and Administrative
17,935,000
18,955,000
15,680,000
11,693,000
11,848,000
Total Operating Expenses
27,399,000
28,203,000
23,924,000
16,156,000
16,265,000
Operating Income or Loss
4,561,000
3,757,000
1,056,000
5,162,000
3,198,000
Interest Expense
1,330,000
1,346,000
1,300,000
1,306,000
1,432,000
Income Before Tax
2,501,000
2,501,000
-265,000
3,916,000
1,548,000
Income Tax Expense
-792,000
-792,000
-380,000
772,000
321,000
Income from Continuing Operations
3,293,000
3,293,000
115,000
3,144,000
1,227,000
Net Income
3,288,000
3,288,000
112,000
3,196,000
1,335,000
Net Income available to common shareholders
3,288,000
3,288,000
112,000
3,196,000
1,335,000
Basic EPS
-
2.12
0.08
2.44
1.03
Diluted EPS
-
2.11
0.08
2.44
1.03
Basic Average Shares
-
1,548,000
1,418,000
1,312,000
1,301,000
Diluted Average Shares
-
1,560,000
1,427,000
1,313,000
1,301,000
EBITDA
-
9,327,000
7,565,000
8,371,000
6,742,000
Data Disclaimer
Help
Suggestions
Terms (Updated)
Privacy
Privacy Dashboard
About Our Ads
© 2023 Yahoo. All rights reserved.
Finance
News
Taxes
Watchlists
My Portfolio
Real Estate
My Screeners
Tech
Market Data
Industry News
Currency Converter